5.2 Thyroid Emergencies (Storm and Myxoedema) and Adrenal Insufficiency
Key Takeaways
Thyroid storm is severe clinical decompensation in thyrotoxicosis. Burch–Wartofsky scoring supports recognition. Start resuscitation, treat the precipitant and involve endocrine and critical care early.
Treat excess hormone synthesis with a thionamide when appropriate. In thyroid storm where iodide is indicated, the 2026 joint consensus recommends waiting at least one hour after the thionamide.
Suspect myxoedema coma with severe hypothyroidism and altered mental status, hypothermia or cardiorespiratory compromise. Give stress-dose hydrocortisone before thyroid hormone when treating suspected decompensation.
Primary adrenal insufficiency can cause aldosterone deficiency, hyperkalaemia and hyperpigmentation. Central or glucocorticoid-induced insufficiency usually preserves aldosterone.
In suspected adrenal crisis, give hydrocortisone 100 mg IV or IM immediately, resuscitate with isotonic saline and treat hypoglycaemia separately if present. Testing must never delay emergency treatment.
Thyrotoxicosis and Its Causes
Thyrotoxicosis is excess thyroid hormone action. Hyperthyroidism is excess production by the gland. The distinction matters because thionamides inhibit hormone synthesis and do little for destructive thyroiditis. If primary thyrotoxicosis is suspected, interpret TSH with FT4 and FT3, including FT3 when TSH is suppressed but FT4 is normal. Ask about medication and recent iodine exposure.
| Cause | Clinical or diagnostic clues |
|---|---|
| Graves’ disease | TSH-receptor stimulating antibodies drive diffuse thyroid activity. Look for a smooth diffuse goitre, sometimes with a bruit, and thyroid eye disease, such as proptosis or diplopia. Pretibial dermopathy and thyroid acropachy are less common. Test TSH receptor antibodies (TRAb). New changes in acuity or colour vision warrant urgent assessment for optic neuropathy. |
| Toxic nodular hyperthyroidism | Autonomous thyroid tissue, with patchy increased uptake in multinodular goitre or focal uptake in a toxic adenoma. Consider scintigraphy when it will help clarify the cause and radioisotope testing is suitable. |
| Subacute (de Quervain) thyroiditis | Pain and tenderness over the thyroid, sometimes radiating to the jaw or ear, with raised inflammatory markers. Release of stored hormone can be followed by a hypothyroid phase before recovery. Uptake is typically low. Use anti-inflammatory treatment for pain, such as an NSAID where suitable or a corticosteroid when indicated. |
| Amiodarone-associated dysfunction | Amiodarone can cause hypothyroidism or thyrotoxicosis. Type 1 thyrotoxicosis reflects excess synthesis in a susceptible thyroid. Type 2 is destructive thyroiditis. Mixed forms occur. Discuss drug and thyroid treatment decisions with cardiology and endocrinology. |
Treatment and Referral
Graves’ hyperthyroidism can be treated with antithyroid drugs, radioiodine or surgery. Select by clinical status, pregnancy plans, eye disease, goitre and patient preference. Check full blood count and liver function before routine thionamide treatment. Explain that fever or sore throat can signal agranulocytosis and requires stopping the drug pending urgent assessment and a blood count. In children with Graves’ disease, involve paediatric endocrinology. The ETA recommends carbimazole or methimazole and advises avoiding propylthiouracil for routine paediatric treatment because of hepatic risk.
Pregnancy. Use assay- and gestation-specific thyroid ranges where available and seek obstetric and endocrine guidance. Transient gestational thyrotoxicosis can accompany hyperemesis and differs from Graves’ disease. When Graves’ requires antithyroid treatment in the first trimester, propylthiouracil is usually preferred under specialist care. Radioiodine is contraindicated during pregnancy.
Nodules. Assess symptoms, neck examination, TSH and ultrasound risk features. A low TSH can prompt scintigraphy to identify a functioning nodule. If the nodule is not hyperfunctioning, use ultrasound risk category and size to determine whether fine-needle aspiration is indicated. Rapid growth, hoarseness, obstructive symptoms or suspicious nodes require prompt assessment.
NICE thyroid disease guidance · ETA amiodarone guideline · ETA thyroid nodules · ETA paediatric Graves’ disease · RCOG pregnancy guidance · ATA 2026 pregnancy guideline
Thyroid Storm Recognition
Thyroid storm is an emergency in which thyrotoxicosis causes systemic decompensation. An infection, surgery, trauma, missed antithyroid treatment, iodine exposure, ketoacidosis or childbirth can precipitate it. The degree of thyroid hormone elevation alone cannot distinguish storm from uncomplicated thyrotoxicosis. Look for high fever, marked tachycardia or an arrhythmia, heart failure, altered mental status and gastrointestinal or hepatic involvement. Consider overlapping diagnoses such as sepsis and treat the likely trigger.
The Burch–Wartofsky Point Scale adds points for thermoregulatory, cardiovascular, neurological and gastrointestinal or hepatic findings and for a precipitant. The 2026 joint consensus uses it as an adjunct:
- A score of 45 or more strongly supports storm in the appropriate context.
- A score of 25–44 raises concern for impending storm, depending on clinical findings.
- A score below 25 makes storm less likely. If suspicion remains high, reassess the findings and the trend with specialist input.
In a patient with a heart rate of 132 beats/min (20 points), ECG-confirmed atrial fibrillation (10), a temperature of 41 °C (30) and agitation (10), these findings alone give 70 points. An irregular pulse should prompt an ECG before assigning points for atrial fibrillation. Other acute illnesses can contribute points. Begin treatment based on clinical suspicion and reassess rather than waiting for a numerical confirmation.
ETA, BTA, Society for Endocrinology and WEDS 2026 thyroid storm consensus
Thyroid Storm Treatment
Start airway, breathing and circulation assessment, organ support and treatment of the precipitant in parallel with addressing thyrotoxicosis. Obtain blood tests and ECG promptly without waiting for biochemical confirmation before treating a convincing emergency. Involve endocrinology and critical care. Monitor perfusion, hypoxaemia, temperature, electrolytes and cardiac function. Give appropriate fluids, cooling and paracetamol if indicated. Avoid aspirin for fever because it can increase free thyroid hormone by displacing protein-bound hormone.
- Control adrenergic effects when tolerated. Propranolol can control tachycardia in a stable patient without significant ventricular dysfunction. Assess haemodynamics and cardiac function early. In suspected low-output heart failure or evolving shock, beta blockade can precipitate collapse. Any titration of a short-acting agent such as IV esmolol requires close specialist monitoring.
- Block new synthesis when increased synthesis is driving disease. The 2026 joint consensus includes high-dose carbimazole, methimazole or propylthiouracil (PTU). PTU also inhibits peripheral T4-to-T3 conversion, but has no clear clinical outcome advantage and carries a risk of severe liver injury. Select using the clinical context, pregnancy status, hepatic function and local availability. Destructive thyroiditis needs a different approach.
- Give iodide when indicated. In synthesis-driven disease such as Graves’ disease, short-term iodide can reduce hormone release. Give it at least one hour after the initial thionamide as recommended in the 2026 consensus, because providing iodine substrate before the synthesis block may worsen hormone production. The role differs for destructive thyroiditis and iodine-loaded conditions such as amiodarone-associated thyrotoxicosis.
- Give stress-dose glucocorticoids early. The 2026 consensus uses hydrocortisone 100 mg IV initially, then 50 mg IV every six hours. Glucocorticoids address possible adrenal insufficiency and inhibit peripheral T4-to-T3 conversion. They can start while other treatment is being organised.
Reassess response and toxicity with the team. Plan definitive therapy after stabilisation and consult a specialist centre about rescue options for severe refractory cases.
Hypothyroidism and Myxoedema Coma
Primary hypothyroidism typically shows high TSH and low FT4. Consider autoimmune thyroiditis or a history of thyroid surgery, radioiodine or relevant medication. Lithium and amiodarone can affect thyroid function. Follow the HSE lithium monitoring checklist for thyroid testing during therapy. Levothyroxine is first-line replacement in usual primary hypothyroidism. Titrate with TSH alongside clinical assessment. In pregnancy use the applicable reference range and arrange early review of replacement requirements. Congenital hypothyroidism is included in Irish newborn bloodspot screening. A concerning result requires prompt specialist confirmation and treatment.
Central hypothyroidism can present with low FT4 and a low or inappropriately normal TSH after pituitary disease or treatment. Assess other pituitary axes. Establish that adrenal cortisol response is intact before starting levothyroxine, or give glucocorticoid cover when adrenal insufficiency cannot be excluded. Thyroid replacement alone in untreated combined deficiency can precipitate adrenal crisis. Use FT4 with clinical assessment to monitor central replacement.
Recognise Decompensation
Myxoedema coma is severe decompensated hypothyroidism. Patients may be lethargic or confused and need urgent care even while conscious. Look for hypothermia, hypoventilation, bradycardia, hypotension, hyponatraemia and hypoglycaemia. Dry skin, nonpitting oedema, macroglossia and delayed reflex relaxation can be clues. Look for precipitating infection, stroke, myocardial events, cold exposure and sedating medication. Consider other contributors to abnormal consciousness and haemodynamics.
- Support ventilation and circulation. Involve critical care and endocrinology early. Provide ventilation as needed. Use passive warming with blankets and cautious IV volume support with reassessment. Treat hypoglycaemia and monitor serum sodium during correction.
- Cover the adrenal axis. If feasible, draw cortisol and ACTH before treatment. The 2026 consensus gives hydrocortisone 100 mg IV initially and then 50 mg every six hours or 200 mg over 24 hours, starting before thyroid replacement. Reassess steroid need after adrenal evaluation.
- Replace thyroid hormone. The 2026 consensus starts IV levothyroxine, generally 200–400 micrograms initially, with 100–200 micrograms considered for older or smaller patients and those with ischaemic heart disease or significant arrhythmia. Follow with daily replacement, adjusted for weight, route, response and cardiac status. Liothyronine is a specialist option for selected cases, such as poor early improvement. High doses risk cardiac complications.
- Identify and treat the trigger. Infection can be present without a typical febrile response. Investigate promptly and use appropriate empirical antimicrobials according to the clinical findings and local hospital policy. Monitor clinical progress and serial FT4 and FT3, since TSH does not normalise immediately.
2026 myxoedema coma consensus · ETA central hypothyroidism · HSE lithium monitoring · HSE congenital hypothyroidism screening
Adrenal Insufficiency and Adrenal Crisis
| Finding | Primary adrenal insufficiency | Central or glucocorticoid-induced adrenal insufficiency |
|---|---|---|
| Causes | Autoimmune adrenalitis, infection such as tuberculosis, bilateral adrenal haemorrhage and other adrenal pathology | Pituitary or hypothalamic disease, pituitary surgery, or suppression after exposure to glucocorticoids |
| Hormones | Cortisol low. ACTH typically high. Aldosterone may also be deficient. | Cortisol low with low or inappropriately normal ACTH. Aldosterone regulation is usually preserved. |
| Clinical clues | Fatigue, weight loss, postural symptoms and salt craving. Raised ACTH can cause pigmentation of creases, scars and mucosa. | Fatigue, weight loss and possible postural symptoms. Hyperpigmentation is usually absent. Other pituitary deficits may coexist. |
| Electrolytes | Hyponatraemia and hyperkalaemia can occur. They may be absent early. | Hyponatraemia can occur. Potassium is often normal unless another condition affects it. |
| Replacement | Glucocorticoid plus fludrocortisone if aldosterone deficient | Glucocorticoid replacement when indicated. Fludrocortisone is usually unnecessary. |
Stable Patient Testing
Use an 8–9 am serum cortisol and interpret against the local assay and circumstances. In NICE NG243 with modern immunoassays, below 150 nmol/L suggests adrenal insufficiency should be considered, 150–300 is indeterminate and above 300 makes it very unlikely in the usual setting. Consider confounders such as exogenous glucocorticoids, pregnancy and oral oestrogen. An arbitrary random cortisol cannot rule out stable adrenal insufficiency.
The adult short Synacthen test typically uses 250 micrograms tetracosactide with baseline and timed post-dose cortisol, commonly at 30 minutes with or without a 60-minute specimen according to the protocol. The stimulated threshold is assay- and timing-dependent. The historical 500 nmol/L threshold is inappropriate for some newer assays. Recent central injury can also yield a reassuring response before adrenal atrophy develops. For confirmed cortisol deficiency, ACTH greater than twice the local upper limit supports a primary cause. Measure renin and aldosterone when mineralocorticoid deficiency is suspected, and investigate aetiology with the specialist team.
Suspected Crisis
Think of adrenal crisis with shock or hypotension, vomiting, abdominal pain, weakness, altered mental status, hypoglycaemia or electrolyte disturbances. It can be the first presentation or occur after inadequate stress dosing, missed treatment, abrupt withdrawal of long-term glucocorticoids or acute illness. Take cortisol and ACTH before treatment if feasible without delay.
- Give 100 mg hydrocortisone IV or IM immediately in adults. Continue 200 mg over 24 hours or 50 mg every six hours in the acute phase with specialist review. When high-dose hydrocortisone provides sufficient mineralocorticoid activity, additional fludrocortisone is unnecessary. Review it as the dose falls in primary deficiency.
- Give IV 0.9% sodium chloride to restore perfusion. NICE NG243 uses an initial litre over 30 minutes in adult crisis, then reassessment according to volume status, electrolytes and cardiac or renal reserve. Treat documented hypoglycaemia promptly with separate IV glucose when oral treatment is unsafe and recheck the response. Monitor ECG and treat clinically important hyperkalaemia in parallel under the applicable acute protocol.
- Monitor haemodynamics, urine output, glucose and electrolytes and treat the precipitant. Arrange endocrine follow-up, sick-day education, emergency injection training and a steroid emergency card when indicated.
When Cortisol Excess Is Suspected
Consider Cushing’s syndrome with progressive features such as wide violaceous striae, proximal weakness or easy bruising. Weight gain accompanied by slowing linear growth is a clue in children. First ask about oral, inhaled, topical or injected glucocorticoid exposure. If endogenous excess remains plausible, refer for appropriate first-line tests such as late-night salivary cortisol, 24-hour urinary free cortisol or an overnight dexamethasone suppression test. In children use specialist protocols. Random cortisol or an incidental pituitary lesion alone cannot establish the diagnosis. Establish cortisol excess before testing for a pituitary, ectopic or adrenal cause.
NICE NG243 · Endocrine Society primary adrenal insufficiency · Society for Endocrinology adrenal crisis · IAEM adult hypoglycaemia in the ED · Endocrine Society Cushing’s syndrome · Paediatric pituitary consensus
A 38-year-old woman with Graves’ disease develops severe thyrotoxicosis with agitation, a temperature of 41.0 °C and a regular pulse of 164 beats/min. Her Burch–Wartofsky score is 65, and the team treats clinically suspected thyroid storm. They initiate supportive care, stress-dose hydrocortisone and a thionamide. They decide to use Lugol’s iodine. Why does the 2026 joint consensus advise waiting at least one hour after the thionamide before giving the iodine?
Co-administration of iodine accelerates hepatic metabolism and clearance of propylthiouracil, rendering it therapeutically inactive
Simultaneous administration causes competitive displacement of propylthiouracil from plasma albumin, increasing free drug toxicity
Iodine administered immediately induces acute histamine release and severe anaphylactoid laryngeal oedema when mixed with thionamides
In synthesis-driven thyrotoxicosis, iodide given before a thionamide can supply substrate for new thyroid hormone production
A 52-year-old man who underwent transsphenoidal resection of a non-functioning pituitary macroadenoma 4 months ago presents to the acute medical unit with progressive fatigue, cold intolerance, dry skin, and constipation. Laboratory testing reveals: TSH 1.2 mU/L (reference range 0.4–4.0) and Free T4 6.8 pmol/L (reference range 12.0–22.0), confirming central hypothyroidism. His baseline blood pressure is 108/68 mmHg. What is the most critical investigation or intervention that must be executed prior to starting levothyroxine replacement therapy?
Evaluate adrenal axis function and initiate glucocorticoid replacement if deficient, prior to administering levothyroxine
Administer an immediate intravenous loading dose of liothyronine (T3) 20 mcg to rapidly normalize cellular metabolic rate
Perform a thyroid ultrasound with fine-needle aspiration biopsy to exclude concurrent autoimmune thyroiditis
Perform an urgent contrast-enhanced CT scan of the neck to assess for tracheal deviation
A 34-year-old woman is brought to the resuscitation room with profound collapse, intractable vomiting, and severe diffuse abdominal pain. She has a 6-month history of unexplained weight loss, generalized weakness, and hyperpigmentation of her palmar creases and buccal mucosa. Vital signs reveal blood pressure 72/40 mmHg refractory to a 500 mL bolus of 0.9% saline, heart rate 124 bpm, and capillary blood glucose 2.8 mmol/L. Serum biochemistry demonstrates: sodium 124 mmol/L, potassium 6.3 mmol/L, urea 16.8 mmol/L, and creatinine 142 µmol/L. What is the most appropriate definitive immediate medical management?
Withhold all corticosteroids until a formal 60-minute Short Synacthen Test can be executed in the intensive care unit
Give hydrocortisone 100 mg IV immediately and resuscitate with 0.9% saline. Correct hypoglycaemia promptly with separate IV glucose
Administer oral fludrocortisone 200 mcg stat and infuse 10 units soluble insulin in 50 mL 50% dextrose to treat hyperkalaemia
Administer intravenous noradrenaline infusion via a central venous catheter as primary monotherapy for refractory shock
Sections you finish are checked off in the contents.